
HCA Healthcare (HCA) Stock Forecast & Price Target
HCA Healthcare (HCA) Analyst Ratings
Bulls say
HCA Healthcare is well-positioned with a substantial presence in the fastest-growing markets in the United States, along with having a leading position in primary urban markets and a diverse business mix. The company's efforts in sustainability, including significant reductions in construction waste, energy use, and water consumption, also bode well for its long-term future. Despite recent headwinds from respiratory illness and unfavorable weather, the company's core growth trends are expected to improve in the second half of 2026 and remain consistent with its original plans, supporting a positive outlook from analysts and a "buy" rating with a price target of $535 per share.
Bears say
HCA Healthcare is likely to struggle in the near-term due to lower hospital volume and mix, as well as higher competition in the market and challenges related to reimbursement from government healthcare programs. Additionally, supply shortages in certain markets could impact productivity and margins. While the company has a strong track record of operational performance, investors may want to exercise caution in the face of these current headwinds.
This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.
HCA Healthcare (HCA) Analyst Forecast & Price Prediction
Start investing in HCA Healthcare (HCA)
Order type
Buy in
Order amount
Est. shares
0 shares